Part 1: Informed Consent, Decision-Making Capacity, and Surrogates: A Discussion with Attorney Rachel Rose

Episode Date: June 16, 2026

In this episode of Stark Integrity, host Bob Wade (“Captain Integrity”) welcomes healthcare attorney Rachel Rose for Part 1 of a three-part discussion on informed consent, decision-making capacity, and surrogate decision-making. While these concepts are often associated with ethics and clinical care, they also carry significant legal, compliance, and risk-management implications for healthcare organizations and providers.

The discussion centers on a fundamental principle of healthcare: the patient's right to autonomy. Patients have the right to understand their medical options and make informed decisions about their care. However, ensuring that this right is respected requires more than simply obtaining a signature on a consent form.

Understanding the Difference Between Informed Consent and Decision-Making Capacity

One of the key themes of the episode is the distinction between informed consent and decision-making capacity.

Although the terms are often used together, they represent different concepts. Informed consent is the process by which a patient receives sufficient information regarding a proposed treatment, including its risks, benefits, and alternatives, and voluntarily agrees to proceed. Decision-making capacity refers to the patient's ability to understand that information, evaluate it, and make an informed choice.

The discussion emphasizes that a signed consent form alone does not necessarily establish informed consent. The quality of communication between provider and patient matters just as much as the documentation itself. Patients must genuinely understand what is being proposed and have the opportunity to ask questions before agreeing to treatment.

Lessons from Recent Cases

Rachel highlights several recent cases demonstrating the importance of informed consent and decision-making capacity in today's healthcare environment. These cases illustrate how questions regarding patient understanding and autonomy can quickly evolve into legal and compliance concerns.

Healthcare organizations should recognize that failures in the informed consent process may create exposure beyond clinical risk, potentially resulting in litigation, regulatory scrutiny, or reputational harm.

Assessing Decision-Making Capacity

Another important takeaway from the episode is that decision-making capacity is not always a permanent or all-or-nothing determination.

A patient's ability to make healthcare decisions may vary depending on the complexity of the decision and the individual's medical condition at a particular point in time. Providers should evaluate whether a patient can:

• Understand relevant information
• Appreciate the consequences of a decision
• Reason through available options
• Communicate a choice

When questions arise regarding a patient's capacity, additional evaluation and documentation may be necessary to protect both the patient and the provider.

The Role of Surrogate Decision-Makers

The episode also explores the role of surrogate decision-makers when a patient lacks decision-making capacity.

Whether through advance directives, healthcare powers of attorney, or other legally recognized mechanisms, surrogates are often called upon to make healthcare decisions on behalf of patients who cannot do so themselves. The objective is to honor the patient's known wishes, values, and best interests whenever possible.

Identifying the appropriate surrogate and ensuring decisions are made consistently with the patient's preferences can be challenging, particularly during emotionally charged medical situations. This makes clear policies and proper documentation essential components of an effective compliance framework.

Protecting Patients and Providers

A recurring theme throughout the discussion is that informed consent and capacity assessments serve to protect both patients and providers.

Healthcare organizations can strengthen these safeguards by:

• Providing ongoing staff education and training
• Establishing clear informed consent policies
• Maintaining thorough documentation
• Implementing procedures for addressing capacity concerns
• Ensuring appropriate involvement of surrogate decision-makers when necessary

The more thoughtful and consistent the process, the greater the protection for all parties involved.

Practical Takeaways

The central takeaway from this episode is that informed consent is a process, not a form.

Patients should feel empowered to ask questions, understand alternatives, and carefully evaluate proposed treatments before proceeding. Providers should focus on meaningful communication, not merely obtaining signatures. Meanwhile, healthcare organizations should view informed consent and capacity assessments as critical components of both patient care and compliance efforts.

Final Thoughts

This episode reinforces that informed consent, decision-making capacity, and surrogate decision-making are far more than legal requirements. They are foundational safeguards that uphold patient autonomy while reducing risk for providers and healthcare organizations.

As Rachel Rose and Captain Integrity discuss, the strongest compliance programs recognize that protecting patient rights and promoting sound decision-making are not separate objectives—they are fundamentally connected. This conversation provides valuable guidance for healthcare leaders, compliance professionals, legal teams, providers, and patients alike.

Click here to listen to this Stark Integrity Podcast Episode:
https://podcasts.apple.com/us/podcast/part-1-informed-consent-decision-making-capacity-and/id1588939373?i=1000773057656